Thimerosal causes synthesis and/or release of both endothelium-derived relaxing factor (EDRF) and prostaglandins from conductance vessels in vitro. We tested its effects and mechanism of action on mouse pial arterioles in vivo using intravital microscopic techniques. Topical thimerosal dilated pial arterioles. This effect was eliminated by endothelial injury produced by a laser/ Evans blue technique. Dilation was also eliminated by topical L-NMMA, a reported inhibitor of EDRF synthe sis. Topical thimerosal also reduced the incidence of platelet adhesion/aggregation ("capture ") at a site of min imal endothelial damage. This effect was eliminated by L-NMMA pretreatment. The ability of thimerosal to di late arterioles was eliminated not only by treatments
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We have published evidence that "classical" en dothelium-dependent relaxing factor (EDRF) plays a role both in modulating the tone of mouse pial arterioles in vivo and in modifying the ability of the endothelium of these vessels to attract platelets or initiate platelet aggregation (Rosenblum, 1986 (Rosenblum, , 1988 Rosenblum et aI., 1987 Rosenblum et aI., , 1990b Nishimura et aI. , 1991) . We designate this EDRF as EDRF ACh to signify that it was originally shown to mediate re laxation by acetylcholine (ACh) (Furchgott, 1983) .
Thimerosal (sodium ethylmercurithiosalicylate) activates the synthesis and/or release of both "cIas-thought to eliminate synthesis/release of EDRF, but also by cyclooxygenase inhibitors. However, inhibition of platelet adhesion/aggregation was not affected by cyclo oxygenase inhibition. Thimerosal significantly increased production of prostaglandin E2 recovered from a closed cranial window. We conclude that the dilating effects of thimerosal on diameter require two endothelium-derived agents: EDRF and one or more prostaglandins acting in concert. However, the inhibiting effect of thimerosal on local platelet adhesion/aggregation appears to be caused only by an increase in EDRF at the injured site. Key Words : Thimerosal-EDRF-Prostaglandins-Vaso dilation-Brain microcirculation-Endothelial injury Platelet adhesion/aggregation. sical" endothelium-dependent relaxing factor and prostaglandins (PG) (Forstermann et aI., 1986) . In the present studies, we took advantage of these properties of thimerosal to investigate the relative importance of EDRF ACh and PGs in modulating mi crovascular events in the mouse brain in vivo.
METHODS
Our methods have been described in great detail in nu merous publications (Rosenblum and Zweifach, 1963; Rosenblum, 1971; Rosenblum and Nelson, 1988a,b; Rosenblum et ai., 1990b) . In brief, ICR male mice were anesthetized with urethane and their cerebral surface ar terioles (pial arterioles) exposed by craniotomy. The mice were maintained at 37°C and the cerebral surface was continuously suffused with mock cerebrospinal fluid (El liott and Jasper, 1949) at pH 7.3-7.4. All solutions applied to the surface are maintained within this pH range. Tele vision microscopy and an image splitter were used to monitor and measure the selected segment (Baez, 1966) .
Selective injury of the endothelium was produced by a well-established technique (Rosenblum et ai. , 1987 (Rosenblum et ai. , , 1990a Rosenblum and Nelson, 1988a; Nishimura et ai., 1991) involving the intravenous administration of Evans blue and light from a 6 mW helium-neon laser. Short exposures-20 s in the present studies-have no demon strable effect on either light or electron microscopic structure but eliminate endothelium-dependent re sponses. Longer exposures will eventually result in plate let adhesion and aggregation at the injured site.
To study the effect of thimerosal on platelet adhesion/ aggregation, we utilized our model of so-called platelet "capture" (Nishimura et ai., 1991) . A laser injury was produced by a 20-s exposure to the laser. The site was observed for 3 min to make certain that no platelet aggre gate was produced by this minimal period of exposure to the laser. Then a second injury was made for 20 s at a point 200 ILm upstream. The laser exposure continued until a platelet aggregate was produced at the upstream site. Shortly thereafter, usually within 1 min, a nodule ("white body") of adhering, aggregating platelets sud denly appeared at the previously injured but normal looking downstream site. This represents the selective "capture," by that site, of platelets that had been acti vated as a consequence of the more severe endothelial damage and platelet aggregation upstream (Nishimura et aI., 1991) . If no aggregate appeared at the downstream site after 5 min, we considered this "no capture."
As indices of PG synthesis, PGE2 and 6-keto-PGFJ<x were measured (Ellis et ai., 1990 ) from fluid collected from under a closed cranial window (Rosenblum et aI. , 1989) .
After each experiment, arterial Pc02, P02, and pH val ues were obtained from arterial blood in each mouse. These values attested to the overall condition of the mice and were similar from study to study. The mean ± SD values for all mice were CO2 = 35 ± 5 mm Hg, O2 = 105 ± 14 mm Hg, and pH = 7. 39 ± 0.14.
Drugs used were thimerosal, I-arginine HCl, N-guani dino-L-monomethyl arginine (L-NMMA) acetate, acetyl salicylic acid (ASA), indomethacin (INDO), and prosta cyclin (PGI2) and were all obtained from Sigma (St. Louis, MO, U.S.A. ).
RESULTS
Endothelium-dependent dilation by thimerosal and its inhibition by L-NMMA Diameter was increased by 1 ± 1.5, 7 ± 6, and 12 ± 6% (mean ± SD) for doses of 10 -7, 10 -6 , and 10-5 M, respectively, in 10 mice. Ten additional mice were studied before and after injuring the en dothelium with laser/Evans blue. Before endothelial injury, the pial arterioles (33 ± 3 I-1m in diameter) were dilated by 9 ± 3% by 10-6 M thimerosal ap plied for 3 min. Five minutes after injury, the in jured site was not dilated at all by thimerosal (0 ± 0%). However, 15 min later, a site 100 I-1m away was dilated by 7 ± 3% by thimerosal, showing that elimination of response at the injured site was not due to fatigue of the preparation. In 10 additional mice, dilation by a 3 min application of 10-6 M thimerosal was prevented by a suffusion of 10-6 M L-NMMA begun 10 min earlier. The diameter was J Cereb Blood Flow Metab, Vol. 12, No.4, 1992 34 ± 3 I-1m before L-NMMA and was not signifi cantly different (33 ± 3 j..L m) after L-NMMA, Thimerosal increased the diameter by 8 ± 3% be fore L-NMMA, and not at all after L-NMMA (0 ± 0%). A parallel study of 10 mice (10 arterioles) showed that tachyphylaxis to thimerosal did not oc cur. Thus, the abolition of the response to thimero sal following treatment with L-NMMA cannot be ascribed to tachyphylaxis.
L-NMMA's effect was stereospecific and selec tive. D-NMMA had no effect, and L-NMMA failed to inhibit dilation by 3 x 10-6 M PGI2. Dilation by PGI2 before 10-6 M L-NMMA was 10 ± 6% and was exactly the same (10 ± 6%) after L-NMMA treatment.
Ten arterioles were dilated by 6 ± 3% by 10-5 M applied for 1 min in the absence of INDO. The same arterioles totally failed to dilate if thimerosal was given after 5 min treatment with either 20 I-1g/ml of INDO or 100 I-1g/ml of ASA. In each case, the cy clooxygenase blocker was also present during the administration of the thimerosal.
Thimerosal inhibits platelet "capture" in vivo Table 1 shows three separate studies. In the first, a control group is compared with a thimerosal treated group. Thimerosal at 10-5 M applied for 10 min virtually eliminated the "capture" of platelets by the downstream site of very minor endothelial injury, In the second study, a group treated with INDO, 20 I-1g/ml for 10 min is compared with a group receiving INDO plus thimerosal. In spite of the presence of INDO, thimerosal again eliminated "capture" of platelets. However, L-NMMA totally blocked the inhibitory action of thimerosal as shown in the third study.
Thimerosal induces PG synthesis
Fluid collected from under a closed cranial win dow prior to application of thimerosal had a PGE2 content of 130 ± 38 pg/ml and a 6-keto-F lex content of 243 ± 20 pg/ml (N = 5). After application of thimerosal, the 6-keto-F la content remained rela tively unchanged (272 ± 38 pg/ml) but the PGE2 content rose about fivefold to 673 ± 164 pg/ml (p < 0.0 1, paired t test).
DISCUSSION
These data show the following new findings: (a) the relaxation of mouse pial arterioles by thimerosal is endothelium dependent; (b) the relaxation is blocked by L-NMMA and by INDO or ASA; and (c) thimerosal inhibits platelet "capture" (adhesion/ aggregation) at sites of minimally injured endothe lium in mouse pial arterioles in vivo. This action of thimerosal was not blocked by INDO, but was blocked by L-NMMA. In experiments not shown, thimerosal failed to inhibit platelet aggregation in vitro or ex vivo. Thus, thimerosal's inhibitory effect on platelet aggregation in vivo cannot be due to a direct action of thimerosal on platelets.
Our data support Forstermann et al. 's (1986) con clusion that thimerosal releases both EDRF ACh and PGs. Thus, we prevented dilation by damaging en dothelium and by pretreating with L-NMMA, an in hibitor of EDRF ACh synthesis (Rees et aI., 1989) or an inactivator of EDRF ACh (Rosenblum et aI. , 1992) . Moreover, we showed increased synthesis of PGE2 by thimerosal.
Since dilation by thimerosal was totally blocked by either L-NMMA or by inhibitors of cyclooxygen ase that block PG synthesis (ASA or INDO), we must assume that a PG and EDRF ACh were acting in concert to produce the dilation by thimerosal. The amount of either EDRF ACh or dilating PG released locally by thimerosal was not sufficient, by itself, to dilate the arteriole. There is a known synergy be tween the dilating actions of EDRF ACh and PGIz (Radomski et aI., 1987; Moncada et aI., 1988; Shi makawa et aI., 1988) . However, we did not detect increased production of 6-keto-F la' the stable me tabolite of PGI2• PGEz, which did greatly increase, is not a reported dilator of cerebral blood vessels. Thus, the PG acting in concert with EDRF ACh to mediate thimerosal's dilating action on mouse pial arterioles remains unidentified.
Unlike the situation with respect to diameter, cy clooxygenase inhibitors had no effect on thimero sal's ability to block platelet "capture. " Appar ently, in this preparation the EDRF ACh synthesized and released after application of thimerosal had a more potent effect on local platelet adhesion/ aggregation than on diameter. Thus, the EDRF ACh was sufficient to block adhesion/aggregation even if the synthesis of its "helper" PG was prevented by INDO. However, when the EDRF ACh was reduced by L-NMMA, then thimerosal could no longer in hibit platelet adhesion/aggregation. Indeed, if plate let adhesion to the damaged endothelium is a key step in platelet "capture," then it may be that a "helping" PG is not important. For example, PGI2 and EDRF ACh act synergistically to inhibit platelet aggregation, but PGIz has not been shown to in crease the inhibitory action of EDRF ACh on platelet adhesion (Radomski et aI., 1987) . Since the actual site of platelet adhesion/aggregation is one with en dothelial damage (Rosenblum et aI. , 1987 ; Nish imura et aI. , 199 1), we believe that thimerosal prob ably increases local EDRF ACh levels by increasing synthesis/release of EDRF ACh at adjacent upstream sites, within 100 j.Lm of the damage. It is also pos sible that the capacity of the damaged site to pro duce/release EDRF ACh is enhanced by thimerosal since such damaged sites show only minimal mor phologic alteration and can recover the capacity to produce EDRF ACh in a short period of time (Rosen blum, 1988) .
